Ongoing Projects

Completed Projects

  • Funding Agency: NIH/NCI

  • Award Mechanism: R01 (CA235677)

  • Award Name: Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)

  • Role: PI (Peter Allen, M.D.)

  • Funding Agency: NIH/NCI

  • Award Mechanism: T32 (CA093245)

  • Award Name: Translational research in surgical oncology

  • Role: PI (Peter Allen, M.D.)

  • Funding Agency: NIH/NCI

  • Award Mechanism: R01 CA182076

  • Award Name: Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas

  • Role: PI (Peter Allen, M.D.)

  • Funding Agency: NIH/NCI

  • Award Mechanism: U01 (CA152653)

  • Award Name: Detection of Pre-Invasive Pancreatic Cysts Using Protein and Glycan Biomarkers

  • Role: PI (Peter Allen, M.D.)

  • Funding Agency: Hopper-Belmont Foundation

  • Award Mechanism: Inspiration Award

  • Award Name: Profiling Hepatic Immune Populations to Target Occult Liver Metastases in Pancreatic Cancer

  • Role: PI (Daniel Nussbaum, M.D.)

  • Funding Agency: Duke Cancer Institute

  • Award Mechanism: Pilot Research Award

  • Award Name: Leveraging MDS Technology to Approach the “Needle in A Haystack” Problem of Occult Liver Metastasis in Pancreatic Adenocarcinoma

  • Role: Co-PI (Daniel Nussbaum, M.D.)

  • Funding Agency: Duke University Office of Physician-Scientist Development

  • Award Mechanism: Strong Start Award

  • Award Name: Deciphering Mechanisms of Hepatic Immunity Governing Pancreatic Cancer Liver Metastasis

  • Role: PI (Daniel Nussbaum, M.D.)

  • Funding Agency: NIH/NCI

  • Award Mechanism: R01 (CA208401)

  • Award Name: Protein and proteolytic activity biomarkers of early stage pancreatic cancer

  • Role: Co-PI (Peter Allen, M.D.)

  • Funding Agency: DoD/CDMRP

  • Award Mechanism: Idea Award (W81XWH-16-1-0271)

  • Award Name: Somatic mosaicism for cancer predisposition genes and pancreatic cancer

  • Role: Co-PI (Peter Allen, M.D.)

  • Funding Agency: NIH/NCI

  • Award Mechanism: U01 (CA086402)

  • Award Name: EDRN Pancreatic Cyst Reference Set

  • Role: Co-PI (Peter Allen, M.D.)

  • Funding Agency: NIH/NCI

  • Award Mechanism: R21 (CA158267)

  • Award Name: Antibody bead array technology for diagnosis of pre-invasive pancreatic cancer

  • Role: PI (Peter Allen, M.D.)

  • Funding Agency: Lustgarten Foundation for Pancreatic Cancer Research

  • Award Mechanism: Early Detection

  • Award Name: Serum and cyst fluid markers for the early detection of pancreatic cancer

  • Role: Co-PI (Peter Allen, M.D.)

  • Funding Agency: Novartis

  • Award Mechanism: Investigator-Initiated Trial

  • Award Name: Prospective randomized, double blind, placebo controlled trial of SOM230 for the reduction of post pancreatectomy fistula, leak and abscess

  • Role: PI (Peter Allen, M.D.)

  • Funding Agency: NIH/NCI

  • Award Mechanism: U01 (CA08496)

  • Award Name: Early Detection Research Network: Cyst fluid biomarkers in pre-malignant pancreatic cysts

  • Role: PI (Peter Allen, M.D.)

  • Funding Agency: Society of Surgical Oncology

  • Award Mechanism: Clinical Investigator Award

  • Award Name: Cyst fluid protein expression profiling for the identification of high-risk Intraductal papillary mucinous neoplasm of the pancreas

  • Role: PI (Peter Allen, M.D.)

  • Funding Agency: NIH/NCI

  • Award Mechanism: Core Grant Funding

  • Award Name: Pancreatic cancer pre-validation reference set for serum/plasma biomarkers

  • Role: Co-PI (Peter Allen, M.D.)

  • Funding Agency: Sanofi-Aventis

  • Award Mechanism: Investigator-Initiated Trial

  • Award Name: Phase II (Pilot) Study of neoadjuvant gemcitabine and oxaliplatin in patients with potentially resectable previously untreated pancreatic adenocarcinoma

  • Role: Co-PI (Peter Allen, M.D.)

  • Funding Agency: NIH/NCI

  • Award Mechanism: Early Stage Surgeon Scientist Program (3P30-CA014236-49S1)

  • Award Name: Deciphering Mechanisms of Hepatic Immunity Governing Pancreatic Cancer Liver Metastasis

  • Role: Participant (Daniel Nussbaum, M.D.)